Posts

Tom Vercauteren appointed Senior Editor for Medical Image Analysis (MedIA) Journal

Tom Vercauteren has been appointed as Senior Editor for the highly-ranked Medical Image Analysis journal, an official journal of the MICCAI society. Sebastien Ourselin also features on the editorial board of the publication.

PhD opportunity [October 2024 start] on "Text promptable semantic segmentation of volumetric neuroimaging data"

Applications are invited for the fully funded 4 years full-time PhD studentship (including home tuition fees, annual stipend and consumables) starting on 1st June 2022.

Award details:

Text promptable semantic segmentation of volumetric neuroimaging data.
Text promptable semantic segmentation of volumetric neuroimaging data.

Project Overview

Semantic segmentation of brain structures from medical images, in particular Magnetic Resonance Imaging (MRI), plays an important role in many neuroimaging applications. Deep learning based segmentation algorithms are now achieving state-of-the-art segmentation results but currently require large amounts of annotated data under predefined segmentation protocols and data inclusion/exclusion criteria. The rigidity of such approaches forbids natural interactions by humans and thus limits the usefulness for non-routine questions.

Science for tomorrow's neurosurgery: Patient & Public Involvement (PPI) group - September 2023 group meeting

On 21st September we held our fourth ‘Science for Tomorrow’s Neurosurgery’ PPI group meeting online, with presentations from Oscar, Matt and Silvère. Presentations focused on an update from the NeuroHSI trial, with clear demonstration of improvements in resolution of the HSI images we are now able to acquire; this prompted real praise from our patient representatives, which is extremely reassuring for the trial going forward. We also took this opportunity to announce the completion of the first phase of NeuroPPEYE, in which we aim to use HSI to quantify tumour fluorescence beyond that which the human eye can see. Discussions were centered around the theme of “what is an acceptable number of participants for proof of concept studies,” generating very interesting points of view that ultimately concluded that there was no “hard number” from the patient perspective, as long as a thorough assessment of the technology had been carried out. This is extremely helpful in how we progress with the trials, particularly NeuroPPEYE, which will begin recruitment for its second phase shortly. Once again, the themes and discussions were summarized in picture format by our phenomenal illustrator, Jenny Leonard (see below) and we are already making plans for our next meeting in February 2024!